GUIDELINES FOR THE MANAGEMENT OS COMMUNITY-ACQUIRED PNEUMONIA: Current Recommendations and Antibiotic Selection Issues

This publication has 38 references indexed in Scilit:

• Bacteremic Pneumonia Due to Multidrug-Resistant Pneumococci in 3 Patients Treated Unsuccessfully with Azithromycin and Successfully with Levofloxacin
  Clinical Infectious Diseases, 2000
• Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
  Clinical Infectious Diseases, 2000
• Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997
  American Journal of Public Health, 2000
• Decreased Susceptibility ofStreptococcus pneumoniaeto Fluoroquinolones in Canada
  New England Journal of Medicine, 1999
• Pneumococcal macrolide resistance—myth or reality?
  Journal of Antimicrobial Chemotherapy, 1999
• Community‐Acquired Pneumonia in Adults: Guidelines for Management
  Clinical Infectious Diseases, 1998
• Variations in Antimicrobial Use and Cost in More Than 2,000 Patients with Community-acquired Pneumonia
  The American Journal of Medicine, 1998
• Multivariate Analysis of Risk Factors for Infection Due to Penicillin‐Resistant and Multidrug‐ResistantStreptococcus pneumoniae: A Multicenter Study
  Clinical Infectious Diseases, 1997
• A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia
  New England Journal of Medicine, 1997
• Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group
  Antimicrobial Agents and Chemotherapy, 1994